Liminal BioSciences Inc.

Liminal BioSciences Inc.verified

LMNL

Price:

$8.5

Market Cap:

$38.38M

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and ch...[Read more]

Industry

Biotechnology

IPO Date

2009-12-18

Stock Exchange

NASDAQ

Ticker

LMNL

The PE Ratio as of November 2025 (TTM) for Liminal BioSciences Inc. (LMNL) is -1.24

According to Liminal BioSciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.24. This represents a change of 10.41% compared to the average of -0.01 of the last 4 quarters.

Liminal BioSciences Inc. (LMNL) Historical PE Ratio (quarterly & annually)

How has LMNL PE Ratio performed in the past?

The mean historical PE Ratio of Liminal BioSciences Inc. over the last ten years is 8.32. The current -1.24 PE Ratio has changed -1595.97% with respect to the historical average. Over the past ten years (40 quarters), LMNL's PE Ratio was at its highest in in the December 2014 quarter at 28.00. The PE Ratio was at its lowest in in the December 2015 quarter at -46.03.

Quarterly (TTM)
Annual

Average

8.32

Median

-0.58

Minimum

-37.87

Maximum

172.18

Liminal BioSciences Inc. (LMNL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Liminal BioSciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 172.18

Minimum Annual Increase = -745.11%

Minimum Annual PE Ratio = -37.87

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.01-50.22%
2021-0.03-30.30%
2020-0.04-5.51%
2019-0.04-96.52%
2018-1.13-88.56%
2017-9.86-26.04%
2016-13.33-64.81%
2015-37.87-121.99%
2014172.18-745.11%
2013-26.69-107.10%

Liminal BioSciences Inc. (LMNL) Average PE Ratio

How has LMNL PE Ratio performed in the past?

The current PE Ratio of Liminal BioSciences Inc. (LMNL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-0.03

5-year avg

-0.25

10-year avg

8.32

Liminal BioSciences Inc. (LMNL) PE Ratio vs. Peers

How is LMNL’s PE Ratio compared to its peers?

Liminal BioSciences Inc.’s PE Ratio is less than Freeline Therapeutics Holdings plc (-0.29), greater than Serina Therapeutics, Inc. (-2.76), less than AnPac Bio-Medical Science Co., Ltd. (-0.56), greater than LakeShore Biopharma Co., Ltd (-6.35), less than Allakos Inc. (-0.42), less than Angion Biomedica Corp. (-0.27), less than Marinus Pharmaceuticals, Inc. (-0.52), less than Vincerx Pharma, Inc. (-0.00), greater than Opus Genetics, Inc. (-2.43), greater than Traws Pharma, Inc. (-1.51),

Build a custom stock screener for Liminal BioSciences Inc. (LMNL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liminal BioSciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Liminal BioSciences Inc. (LMNL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Liminal BioSciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Liminal BioSciences Inc.'s PE Ratio?

How is the PE Ratio calculated for Liminal BioSciences Inc. (LMNL)?

What is the highest PE Ratio for Liminal BioSciences Inc. (LMNL)?

What is the 3-year average PE Ratio for Liminal BioSciences Inc. (LMNL)?

What is the 5-year average PE Ratio for Liminal BioSciences Inc. (LMNL)?

How does the current PE Ratio for Liminal BioSciences Inc. (LMNL) compare to its historical average?